Previous 10 | Next 10 |
Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications PR Newswire REDWOOD CITY, Calif., Nov. 30, 2020 REDWOOD CITY, Calif. , Nov. 30, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device c...
Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th PR Newswire REDWOOD CITY, Calif., Nov. 24, 2020 REDWOOD CITY, Calif. , Nov. 24, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global med...
Nevro Announces Abstract Presentations for PDN and NSRBP Trials Have Been Accepted for the Late Breaking Trials Plenary Session at NANS 2021 Conference Company to Host Investor Briefing to Review Latest Developments PR Newswire REDWOOD CITY, Calif., Nov. 17, 2020 ...
Nevro Corp. (NVRO) Q3 2020 Earnings Conference Call November 5, 2020 16:30 ET Company Participants Keith Grossman - Chairman, Chief Executive Officer & President Roderick MacLeod - Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marc...
Image source: The Motley Fool. Nevro Corp (NYSE: NVRO) Q3 2020 Earnings Call Nov 6, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Nevro Corp (NVRO) Q3 2020 Earnings Call Transcript
Gainers: [[FTSI]] +80%. [[AVNW]] +17.5%. [[AGS]] +16%. [[GLUU]] +15.8%. [[CNDT]] +9.2%.Losers: [[ASMB]] -38.6%. [[GBT]] -30.4%. [[AAOI]] -20.7%. [[MRIN]] -14%. [[NVRO]] -10%. For further details see: GLUU, AAOI, CNDT and GBT among after-hours movers
Nevro (NVRO): Q3 GAAP EPS of -$0.29 beats by $0.30.Revenue of $108.46M (+8.3% Y/Y) beats by $4.46M.Press Release For further details see: Nevro EPS beats by $0.30, beats on revenue
Nevro Announces Third Quarter 2020 Financial Results - Worldwide revenues increase 8% - Nevro to submit PDN PMA Supplement to FDA in fourth quarter 2020 PR Newswire REDWOOD CITY, Calif., Nov. 5, 2020 REDWOOD CITY, Calif. , Nov. 5, 2020 /PRNewswire/ --...
Nevro (NYSE:NVRO) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is -$0.59 (-1.7% Y/Y) and the consensus Revenue Estimate is $104M (+3.8% Y/Y).Over the last 2 years, NVRO has beaten EPS estimates 25% of the time and has be...
Nevro to Report Third Quarter 2020 Financial Results Company to Host Conference Call on Thursday, November 5, 2020 at 1:30 p.m. PT / 4:30 p.m. ET PR Newswire REDWOOD CITY, Calif., Oct. 22, 2020 REDWOOD CITY, Calif. , Oct. 22, 2020 /PRNewswire/ -- Nevro Co...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...